Concurrent chemoimmunotherapy in metastatic clear cell sarcoma

A case report

Salvatore Lauro, Francesca Bordin, Luciana Trasatti, Gaetano Lanzetta, Carlo Delia Rocca, Luigi Frati

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Clear cell sarcoma is a rare tumor with a poor prognosis. The therapeutic approach in the metastatic disease stage is controversial: to the authors' knowledge the use of concurrent chemoimmunotherapy has not been previously reported. We present a case of a 57-year-old male with metastatic clear cell sarcoma treated simultaneously with subcutaneous interferon-α 2b and six courses of chemotherapy according to the CyVEDIC regimen. Disease stabilization lasting 17 months was achieved.

Original languageEnglish
Pages (from-to)512-514
Number of pages3
JournalTumori
Volume85
Issue number6
Publication statusPublished - Nov 1999

Fingerprint

Clear Cell Sarcoma
Interferons
Drug Therapy
Neoplasms
Therapeutics

Keywords

  • Chemoimmunotherapy
  • Clear cell sarcoma

ASJC Scopus subject areas

  • Cancer Research

Cite this

Lauro, S., Bordin, F., Trasatti, L., Lanzetta, G., Rocca, C. D., & Frati, L. (1999). Concurrent chemoimmunotherapy in metastatic clear cell sarcoma: A case report. Tumori, 85(6), 512-514.

Concurrent chemoimmunotherapy in metastatic clear cell sarcoma : A case report. / Lauro, Salvatore; Bordin, Francesca; Trasatti, Luciana; Lanzetta, Gaetano; Rocca, Carlo Delia; Frati, Luigi.

In: Tumori, Vol. 85, No. 6, 11.1999, p. 512-514.

Research output: Contribution to journalArticle

Lauro, S, Bordin, F, Trasatti, L, Lanzetta, G, Rocca, CD & Frati, L 1999, 'Concurrent chemoimmunotherapy in metastatic clear cell sarcoma: A case report', Tumori, vol. 85, no. 6, pp. 512-514.
Lauro S, Bordin F, Trasatti L, Lanzetta G, Rocca CD, Frati L. Concurrent chemoimmunotherapy in metastatic clear cell sarcoma: A case report. Tumori. 1999 Nov;85(6):512-514.
Lauro, Salvatore ; Bordin, Francesca ; Trasatti, Luciana ; Lanzetta, Gaetano ; Rocca, Carlo Delia ; Frati, Luigi. / Concurrent chemoimmunotherapy in metastatic clear cell sarcoma : A case report. In: Tumori. 1999 ; Vol. 85, No. 6. pp. 512-514.
@article{685a12c7e88a422a9fc603a37c6fe3e8,
title = "Concurrent chemoimmunotherapy in metastatic clear cell sarcoma: A case report",
abstract = "Clear cell sarcoma is a rare tumor with a poor prognosis. The therapeutic approach in the metastatic disease stage is controversial: to the authors' knowledge the use of concurrent chemoimmunotherapy has not been previously reported. We present a case of a 57-year-old male with metastatic clear cell sarcoma treated simultaneously with subcutaneous interferon-α 2b and six courses of chemotherapy according to the CyVEDIC regimen. Disease stabilization lasting 17 months was achieved.",
keywords = "Chemoimmunotherapy, Clear cell sarcoma",
author = "Salvatore Lauro and Francesca Bordin and Luciana Trasatti and Gaetano Lanzetta and Rocca, {Carlo Delia} and Luigi Frati",
year = "1999",
month = "11",
language = "English",
volume = "85",
pages = "512--514",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - Concurrent chemoimmunotherapy in metastatic clear cell sarcoma

T2 - A case report

AU - Lauro, Salvatore

AU - Bordin, Francesca

AU - Trasatti, Luciana

AU - Lanzetta, Gaetano

AU - Rocca, Carlo Delia

AU - Frati, Luigi

PY - 1999/11

Y1 - 1999/11

N2 - Clear cell sarcoma is a rare tumor with a poor prognosis. The therapeutic approach in the metastatic disease stage is controversial: to the authors' knowledge the use of concurrent chemoimmunotherapy has not been previously reported. We present a case of a 57-year-old male with metastatic clear cell sarcoma treated simultaneously with subcutaneous interferon-α 2b and six courses of chemotherapy according to the CyVEDIC regimen. Disease stabilization lasting 17 months was achieved.

AB - Clear cell sarcoma is a rare tumor with a poor prognosis. The therapeutic approach in the metastatic disease stage is controversial: to the authors' knowledge the use of concurrent chemoimmunotherapy has not been previously reported. We present a case of a 57-year-old male with metastatic clear cell sarcoma treated simultaneously with subcutaneous interferon-α 2b and six courses of chemotherapy according to the CyVEDIC regimen. Disease stabilization lasting 17 months was achieved.

KW - Chemoimmunotherapy

KW - Clear cell sarcoma

UR - http://www.scopus.com/inward/record.url?scp=0033402119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033402119&partnerID=8YFLogxK

M3 - Article

VL - 85

SP - 512

EP - 514

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 6

ER -